Abstract

Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition

Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard

Issue: Sep/Oct 2014 - Volume 18, Number 5

Page(s): 427-431

Download in electronic PDF format for $75
  • Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Page 1
  • Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Page 2
  • Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Page 3
  • Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Page 4
  • Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Page 5

Abstract

Hydrocortisone is principally used as replacement therapy in adrenocortical deficiency states. In pediatric practice, posology ranges from 10 to 20 mg/m. per day, divided in three doses, for the purpose of mimicking the nycthemeral cycle. Hydrocortisone is marketed in France in tablet form that contains 10 mg of the active ingredient. This galenic formulation is not suitable for pediatric use, and often requires a grinding operation or a dose fractionation to facilitate administration. To overcome this difficulty, the objective of this study was to develop and evaluate the physicochemical and microbiological stabilities of hydrocortisone in a sugar-free, alcohol-free, and paraben-free InOrpha suspending agent. The studied samples were formulated into a 2-mg/mL suspension and stored in glass bottles at two temperature conditions, between 2°C to 8°C and at room temperature). Two series of twelve samples were tested for physicochemical stability using high-performance liquid chromatography as well as for a microbiological status for 28 days (daily opening of the bottles from day 0 of compounding) and for 56 days (first opening at day 28 from compounding and daily opening for 28 consecutive days). The high-performance liquid chromatography method developed is linear, accurate, precise, and robust. On the other hand, a forced degradation study has demonstrated the selectivity and specificity of the method validated as stability indicating. In both storage conditions, high-performance liquid chromatography analysis showed that tested samples had concentrations ranging within 90% to 110% of the initial concentration for 28 consecutive days upon daily bottle opening and, for a maximum of 42 days with a first opening at day 28 from the compounding time. Microbiological status remained stable throughout the course of the study. Based on the data collected, the study led to the development of a new galenic formulation of hydrocortisone suitable for pediatric use which can be safely stored under refrigerated conditions or at room temperature for a maximum of 42 consecutive days.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2014
Pg. 427-431
Jan/Feb 2015
Pg. 73-77
Sep/Oct 2021
Pg. 431-439
May/Jun 2007
Pg. 259-261
Author(s): Gupta Vishnu D
Sep/Oct 2010
Pg. 430-435
Jul/Aug 2022
Pg. 330-335
Mar/Apr 2021
Pg. 169-175
Mar/Apr 2023
Pg. 160-168
May/Jun 2003
Pg. 170-174
Author(s): Meece Jerry
Jan/Feb 2018
Pg. 66-75
Jul/Aug 2001
Pg. 310-312
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 342-351
May/Jun 2018
Pg. 240-246
Jul/Aug 2017
Pg. 322-329
Sep/Oct 2020
Pg. 413-419
Jan/Feb 2023
Pg. 72-77
Mar/Apr 2021
Pg. 156-162
Nov/Dec 2018
Pg. 495
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 519-527
Sep/Oct 2003
Pg. 389-393